Ascentage Pharma Group International (AAPG) Operating Leases: 2022-2024

Historic Operating Leases for Ascentage Pharma Group International (AAPG) over the last 3 years, with Dec 2024 value amounting to $4.1 million.

  • Ascentage Pharma Group International's Operating Leases rose 31.49% to $4.1 million in Q4 2024 from the same period last year, while for Dec 2024 it was $4.1 million, marking a year-over-year increase of 31.49%. This contributed to the annual value of $4.1 million for FY2024, which is 33.31% up from last year.
  • According to the latest figures from FY2024, Ascentage Pharma Group International's Operating Leases is $4.1 million, which was up 33.31% from $3.1 million recorded in FY2023.
  • Over the past 5 years, Ascentage Pharma Group International's Operating Leases peaked at $4.1 million during FY2024, and registered a low of $2.6 million during FY2022.
  • In the last 3 years, Ascentage Pharma Group International's Operating Leases had a median value of $3.1 million in 2023 and averaged $3.3 million.
  • Data for Ascentage Pharma Group International's Operating Leases shows a peak YoY spiked of 33.31% (in 2024) over the last 5 years.
  • Over the past 3 years, Ascentage Pharma Group International's Operating Leases (Yearly) stood at $2.6 million in 2022, then climbed by 21.13% to $3.1 million in 2023, then soared by 33.31% to $4.1 million in 2024.